Zhang Yuandong, Li Man, Du Guangsheng, Chen Xiaoyan, Sun Xun
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, No.17, Block 3, Southern Renmin Road, Chengdu 610041, China; School of Pharmacy, Zunyi Medical University, No.6 West Xuefu Road, Xinpu District, Zunyi, Guizhou 563000, China.
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, No.17, Block 3, Southern Renmin Road, Chengdu 610041, China.
Adv Drug Deliv Rev. 2021 Oct;177:113928. doi: 10.1016/j.addr.2021.113928. Epub 2021 Aug 16.
Infectious diseases continue to inflict a high global disease burden. The consensus is that vaccination is the most effective option against infectious diseases. Oral vaccines have unique advantages in the prevention of global pandemics due to their ease of use, high compliance, low cost, and the ability to induce both systemic and mucosal immune responses. However, challenges of adapting vaccines for oral administration remain significant. Foremost among these are enzymatic and pH-dependent degradation of antigens in the stomach and intestines, the low permeability of mucus barrier, the nonspecific uptake of antigens at the intestinal mucosal site, and the immune suppression result from the elusive immune tolerance mechanisms. Innovative delivery techniques promise great potential for improving the flexibility and efficiency of oral vaccines. A better understanding of the delivery approaches and the immunological mechanisms of oral vaccine delivery systems may provide new scientific insight and tools for developing the next-generation oral vaccine. Here, an overview of the advanced technologies in the field of oral vaccination is proposed, including mucus-penetrating nanoparticle (NP), mucoadhesive delivery vehicles, targeting antigen-presenting cell (APC) nanocarriers and enhanced paracellular delivery strategies and so on. Meanwhile, the mechanisms of delivery vectors interact with mucosal barriers are discussed.
Adv Drug Deliv Rev. 2021-10
Adv Drug Deliv Rev. 2015-3-25
J Control Release. 2022-11
PLoS Pathog. 2010-11-11
J Control Release. 2012-2-13
Curr Drug Targets. 2020
Expert Rev Vaccines. 2012-3
Plant Biotechnol J. 2015-9-7
J Control Release. 2016-10-28
Expert Opin Drug Deliv. 2013-2
Acta Pharm Sin B. 2025-8
NPJ Vaccines. 2025-8-1
Research (Wash D C). 2025-7-8
Front Immunol. 2025-6-6
Signal Transduct Target Ther. 2025-3-5
Front Med (Lausanne). 2025-1-6
Pharmaceutics. 2024-9-13